metaEvidence - overview


			deaths (OS)
non squamous - mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) non squamous cell - mNSCLC - L2 non squamous - mNSCLC - L2 - all population
versus docetaxel
	nivolumab alone vs. docetaxel	1	0.73 [0.59; 0.90], 1 RCT, I2=0% conclusive unassessable degree of certainty